221 related articles for article (PubMed ID: 25486274)
1. P2X7 mediates ATP-driven invasiveness in prostate cancer cells.
Qiu Y; Li WH; Zhang HQ; Liu Y; Tian XX; Fang WG
PLoS One; 2014; 9(12):e114371. PubMed ID: 25486274
[TBL] [Abstract][Full Text] [Related]
2. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway.
Xia J; Yu X; Tang L; Li G; He T
Oncol Rep; 2015 Jul; 34(1):103-10. PubMed ID: 25976617
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.
Ghalali A; Wiklund F; Zheng H; Stenius U; Högberg J
Carcinogenesis; 2014 Jul; 35(7):1547-55. PubMed ID: 24451147
[TBL] [Abstract][Full Text] [Related]
5. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells.
Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM
Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010
[TBL] [Abstract][Full Text] [Related]
6. ATP-gated P2X7 receptor as a potential target for prostate cancer.
Qiao C; Tang Y; Li Q; Zhu X; Peng X; Zhao R
Hum Cell; 2022 Sep; 35(5):1346-1354. PubMed ID: 35657562
[TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways.
Bai X; Li Q; Peng X; Li X; Qiao C; Tang Y; Zhao R
Purinergic Signal; 2023 Dec; 19(4):685-697. PubMed ID: 36854856
[TBL] [Abstract][Full Text] [Related]
8. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
Fang WG; Tian XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
[TBL] [Abstract][Full Text] [Related]
9. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
10. P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway.
Li WH; Qiu Y; Zhang HQ; Tian XX; Fang WG
PLoS One; 2015; 10(7):e0133165. PubMed ID: 26182292
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
12. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.
Li W; Dong Y; Zhang B; Kang Y; Yang X; Wang H
Biomed Pharmacother; 2016 Jul; 81():1-6. PubMed ID: 27261570
[TBL] [Abstract][Full Text] [Related]
13. P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death.
Bian S; Sun X; Bai A; Zhang C; Li L; Enjyoji K; Junger WG; Robson SC; Wu Y
PLoS One; 2013; 8(4):e60184. PubMed ID: 23565201
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells.
Ziberi S; Zuccarini M; Carluccio M; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Di Iorio P; Ciccarelli R
Cells; 2019 Dec; 9(1):. PubMed ID: 31905754
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
16. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C
Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689
[TBL] [Abstract][Full Text] [Related]
17. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
18. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
[TBL] [Abstract][Full Text] [Related]
19. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
20. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
